José Zanchetta

17.7k total citations · 3 hit papers
114 papers, 12.3k citations indexed

About

José Zanchetta is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, José Zanchetta has authored 114 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Orthopedics and Sports Medicine, 64 papers in Oncology and 38 papers in Molecular Biology. Recurrent topics in José Zanchetta's work include Bone health and osteoporosis research (79 papers), Bone health and treatments (62 papers) and Bone Metabolism and Diseases (35 papers). José Zanchetta is often cited by papers focused on Bone health and osteoporosis research (79 papers), Bone health and treatments (62 papers) and Bone Metabolism and Diseases (35 papers). José Zanchetta collaborates with scholars based in Argentina, United States and Canada. José Zanchetta's co-authors include Michael R. McClung, Cesar Libanati, Harry K. Genant, Bruce Mitlak, Jean‐Yves Reginster, Richard Eastell, Steven R. Cummings, Claus Christiansen, Erik Fink Eriksen and Robert M. Neer and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

José Zanchetta

109 papers receiving 11.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

2001 3.4k citations Robert M. Neer, Claude D. Arnaud et al. New England Journal of Medicine profile →
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

2009 2.4k citations Steven R. Cummings, Javier San Martín et al. New England Journal of Medicine profile →
Romosozumab in Postmenopausal Women with Low Bone Mineral Density

2014 886 citations Michael R. McClung, Andreas Grauer et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José Zanchetta Argentina	42	8.4k	6.6k	5.1k	2.0k	1.5k	114	12.3k
Henry G. Bone United States	55	7.7k 0.9×	7.6k 1.2×	5.1k 1.0×	1.7k 0.9×	915 0.6×	148	12.3k
Steven T. Harris United States	39	9.7k 1.2×	6.2k 0.9×	3.9k 0.8×	2.9k 1.4×	1.1k 0.7×	76	12.9k
Bruce Mitlak United States	40	6.9k 0.8×	5.5k 0.8×	4.1k 0.8×	2.0k 1.0×	2.2k 1.5×	97	11.1k
Anthony B. Hodsman Canada	47	7.4k 0.9×	5.4k 0.8×	4.1k 0.8×	2.3k 1.1×	804 0.5×	121	11.6k
Felicia Cosman United States	67	11.8k 1.4×	8.1k 1.2×	6.0k 1.2×	3.3k 1.6×	1.4k 0.9×	204	17.0k
Cesar Libanati United States	45	7.1k 0.8×	5.1k 0.8×	4.4k 0.9×	1.8k 0.9×	691 0.5×	150	9.9k
Arthur C. Santora United States	38	8.4k 1.0×	6.2k 0.9×	3.3k 0.6×	2.1k 1.1×	723 0.5×	93	10.4k
Bente Langdahl Denmark	48	4.7k 0.6×	3.3k 0.5×	3.9k 0.8×	1.4k 0.7×	1.4k 1.0×	235	8.9k
Silvano Adami Italy	46	4.9k 0.6×	4.1k 0.6×	2.9k 0.6×	1.3k 0.6×	864 0.6×	142	8.5k
J Štěpán Czechia	40	5.3k 0.6×	3.2k 0.5×	2.6k 0.5×	1.7k 0.8×	1.1k 0.7×	228	8.7k

Countries citing papers authored by José Zanchetta

Since Specialization

Citations

This map shows the geographic impact of José Zanchetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Zanchetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Zanchetta more than expected).

Fields of papers citing papers by José Zanchetta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Zanchetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Zanchetta. The network helps show where José Zanchetta may publish in the future.

Co-authorship network of co-authors of José Zanchetta

This figure shows the co-authorship network connecting the top 25 collaborators of José Zanchetta. A scholar is included among the top collaborators of José Zanchetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Zanchetta. José Zanchetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seeman, Ego, Cesar Libanati, Matthew Austin, et al.. (2012). THE TRANSITORY PTH INCREASE FOLLOWING DENOSUMAB ADMINISTRATION IS ASSOCIATED WITH REDUCED INTRACORTICAL POROSITY: A DISTINCTIVE CHARACTERISTIC OF DENOSUMAB THERAPY. Osteoporosis International. 23. 1 indexed citations

McClung, Michael R., Paul D. Miller, Jacques P. Brown, et al.. (2011). Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet. Osteoporosis International. 23(1). 267–276. 27 indexed citations

Hadji, Peyman, José Zanchetta, Luis Augusto Tavares Russo, et al.. (2011). Effect of teriparatide compared with risedronate on back pain and incident vertebral fractures in postmenopausal women with osteoporotic vertebral fractures. Bone. 48. S82–S83. 2 indexed citations

Seeman, Ego, R. Chapurlat, Albert T. Cheung, et al.. (2010). RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE. Osteoporosis International. 21. 4 indexed citations

Cummings, S. R., Kristine E. Ensrud, Pierre D. Delmas, et al.. (2010). Lasofoxifene in Postmenopausal Women With Osteoporosis. Obstetrical & Gynecological Survey. 65(7). 447–448. 21 indexed citations

Seeman, Ego, Pierre D. Delmas, David A. Hanley, et al.. (2010). Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate. Journal of Bone and Mineral Research. 25(8). 1886–1894. 221 indexed citations

Cosman, Felicia, Nancy E. Lane, Michael A. Bolognese, et al.. (2009). Effect of Transdermal Teriparatide Administration on Bone Mineral Density in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism. 95(1). 151–158. 107 indexed citations

Cummings, Steven R., Javier San Martín, Michael R. McClung, et al.. (2009). Denosumab for Prevention of Fractures in Postmenopausal Women With Osteoporosis. Obstetrical & Gynecological Survey. 64(12). 805–807. 41 indexed citations

Saag, Kenneth G., Jean‐Pierre Devogelaer, José Zanchetta, et al.. (2008). Teriparatide versus Alendronate for Treatment of Glucocorticoid-Induced Osteoporosis: 36-month Results. Journal of Bone and Mineral Research. 23(9). 4 indexed citations

10.

Delmas, Pierre D., C.L. Benhamou, Z. Man, et al.. (2007). Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. Osteoporosis International. 19(7). 1039–1045. 48 indexed citations

11.

Greenspan, Susan L., Henry G. Bone, Mark P. Ettinger, et al.. (2007). Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis. Annals of Internal Medicine. 291 indexed citations

12.

Negri, Armando, et al.. (2006). Relación entre función renal y densidad mineral ósea en mujeres posmenopáusicas que realizan evaluación de masa ósea. Nefrología. 26(2). 206–211.

13.

Cosman, Felicia, Michael R. McClung, Clifford J. Rosen, et al.. (2005). Rationale and design of the MOTION study (monthly oral therapy with ibandronate for osteoporosis intervention).. Journal of Bone and Mineral Research. 20. 2 indexed citations

14.

Zanchetta, José, et al.. (2005). OSTEOPOROSIS DEL EMBARAZO Y LA LACTANCIA. Medicina-buenos Aires. 65(6). 459–494. 2 indexed citations

15.

Massari, Fabio, et al.. (2002). Fenofibrate or Gemfibrozil for Treatment of Types IIa and IIb Primary Hyperlipoproteinemia: A Randomized, Double-Blind, Crossover Study. Endocrine Practice. 8(2). 96–101. 31 indexed citations

16.

Neer, Robert M., Claude D. Arnaud, José Zanchetta, et al.. (2001). Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 344(19). 1434–1441. 3366 indexed citations breakdown →

17.

Neer, Robert M., Catherine Arnaud, José Zanchetta, et al.. (2001). 骨粗鬆症の閉経後女性において骨折と骨密度に対する副甲状腺ホルモン(1-34)の効果. New England Journal of Medicine. 344(19). 1434–1441. 4 indexed citations

18.

Ettinger, Bruce, Dennis M. Black, Bruce Mitlak, et al.. (2000). Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial. Obstetrical & Gynecological Survey. 55(1). 39–39. 116 indexed citations

19.

Gónzalez, Germán E., et al.. (1999). Influence of Age and Sex in Serum Osteocalcin Levels in Thoroughbred Horses. Archives of Physiology and Biochemistry. 107(1). 50–54. 18 indexed citations

20.

Cointry, Gustavo Roberto, et al.. (1995). Intravenous olpadronate restores ovariectomy-affected bone strength. A mechanical, densitometric and tomographic (pQCT) study. Bone. 17(4). S373–S378. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact